Skip to main content
SpringerLink
Log in

Application of Encapsulated Cell Technology for Retinal Degenerative Diseases

  • Chapter
Retinal Degenerations

Part of the book series: Ophthalmology Research ((OPHRES))

Abstract

Encapsulated cell technology (ECT) is essentially a cell-based delivery system that can be used to deliver therapeutic agents to the target tissue, including the central nervous system (CNS) and the eye to treat chronic disorders. In this chapter, we focus on its application in retinal degenerative diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cedarbaum JM. The pharmacokinetics of subcutaneously administered recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis: relation to parameters of the acute-phase response. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. Clin Neuropharmacol 1995;18:500–514.

    Article  CAS  Google Scholar 

  2. Cedarbaum JM. A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. Clin Neuropharmacol 1995;18:515–532.

    CAS  Google Scholar 

  3. Emerich DF, Lindner MD, Winn SR, Chen EY, Frydel BR, Kordower JH. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington’s disease. J Neurosci 1996;16:5168–5181.

    PubMed  CAS  Google Scholar 

  4. Emerich DF, Winn SR, Hantraye PM, et al. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington’s disease. Nature 1997; 386:395–399.

    Article  PubMed  CAS  Google Scholar 

  5. Emerich DF, Plone M, Francis J, Frydel BR, Winn SR, Lindner MD. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res 1996;736:99–110.

    Article  PubMed  CAS  Google Scholar 

  6. Tseng JL, Baetge EE, Zurn AD, Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J Neurosci 1997;17:325–333.

    PubMed  CAS  Google Scholar 

  7. Emerich DF, Hammang JP, Baetge EE, Winn SR. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp Neurol 1994;130:141–150.

    Article  PubMed  CAS  Google Scholar 

  8. Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 1994;349:148–64.

    Article  PubMed  CAS  Google Scholar 

  9. Kordower JH,Winn SR, Liu YT, et al. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 1994;91:10,898–10,902.

    Article  PubMed  CAS  Google Scholar 

  10. Lindner MD, Kearns CE, Winn SR, Frydel B, Emerich DF. Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Transplant 1996;5:205–223.

    Article  PubMed  CAS  Google Scholar 

  11. Hoane MR, Puri KD, Xu L, et al. Mammalian-cell-produced neurturin (NTN) is more potent than purified escherichia coli-produced NTN [In Process Citation]. Exp Neurol 2000;162:189–193.

    Article  PubMed  CAS  Google Scholar 

  12. Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002;43:3292–3298.

    PubMed  Google Scholar 

  13. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24:335–610.

    Article  PubMed  CAS  Google Scholar 

  14. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982;100:571–573.

    PubMed  CAS  Google Scholar 

  15. Martinez GS, Campbell AJ, Reinken J, Allan BC. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 1982;94:181–189.

    PubMed  CAS  Google Scholar 

  16. Gibson JM, Rosenthal AR, Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc UK 1985;104:196–203.

    PubMed  Google Scholar 

  17. Vinding T. Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 1989;67: 609–616.

    Article  CAS  Google Scholar 

  18. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989;107:847–852.

    PubMed  CAS  Google Scholar 

  19. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933–943.

    PubMed  CAS  Google Scholar 

  20. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205–210.

    PubMed  CAS  Google Scholar 

  21. Hawkins BS, Bird A, Klein R, West SK. Epidemiology of age-related macular degeneration. Mol Vis 1999;5:26.

    PubMed  CAS  Google Scholar 

  22. Davis MD, Hiller R, Magli YL, et al. Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc 1979;77:144–170.

    PubMed  CAS  Google Scholar 

  23. Podgor MJ, Cassel GH, Kannel WB. Lens changes and survival in a population-based study. N Engl J Med 1985;313:1438–1444.

    Article  PubMed  CAS  Google Scholar 

  24. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520–526.

    PubMed  CAS  Google Scholar 

  25. Klein R, Moss SE, Klein BE, DeMets DL. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 1989;149:266–272.

    Article  PubMed  CAS  Google Scholar 

  26. Klein R, Klein BE, Moss SE. Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 1995;113:333–339.

    PubMed  CAS  Google Scholar 

  27. Coleman AL. Glaucoma. Lancet 1999;354:1803–1810.

    Article  PubMed  CAS  Google Scholar 

  28. West SK. Looking forward to 20/20: a focus on the epidemiology of eye diseases. Epidemiol Rev 2000;22:64–70.

    PubMed  CAS  Google Scholar 

  29. Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs 2000;59:411–434.

    Article  PubMed  CAS  Google Scholar 

  30. Weih LM, VanNewkirk MR, McCarty CA, Taylor HR. Age-specific causes of bilateral visual impairment. Arch Ophthalmol 2000:118:264–269.

    PubMed  CAS  Google Scholar 

  31. Dryja TP, Li T. Molecular genetics of retinitis pigmentosa. Hum Mol Genet 1995;4: 1739–1743.

    PubMed  CAS  Google Scholar 

  32. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428–433.

    PubMed  CAS  Google Scholar 

  33. Narcisi TM, Shoulders CC, Chester SA, et al. Mutations of the microsomal triglyceridetransfer-protein gene in abetalipoproteinemia. Am J Hum Genet 1995;57:1298–1310.

    PubMed  CAS  Google Scholar 

  34. Meindl A, Dry K, Herrmann K, et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet 1996;13:35–42.

    Article  PubMed  CAS  Google Scholar 

  35. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990;347:83–86.

    Article  PubMed  CAS  Google Scholar 

  36. LaVail MM, Unoki K,Yasumura D, Matthes MT,Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA 1992;89:11,249–11,253.

    Article  PubMed  CAS  Google Scholar 

  37. Unoki K, Ohba N, Arimura H, Muramatsu H, Muramatsu T. Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid-responsive gene product. Invest Ophthalmol Vis Sci 1994;35:4063–4068.

    PubMed  CAS  Google Scholar 

  38. LaVail MM,Yasumura D, Matthes MT, et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998;39:592–602.

    PubMed  CAS  Google Scholar 

  39. Hauswirth WW LQ, Raisler B, Timmers AM, et al. Range of retinal diseases potentially treatable by AAV-vectored gene therapy. Novartis Found Symp 2004:255:179–194.

    Article  PubMed  CAS  Google Scholar 

  40. Lawrence JM KD, Muir EM, Coffey PJ, et al. Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest Ophthalmol Vis Sci. 2004;45:267–274.

    Article  PubMed  Google Scholar 

  41. Machida S CP, Shinohara T, Singh DP, et al. Lens epithelium-derived growth factor promotes photoreceptor survival in light-damaged and RCS rats. Invest Ophthalmol Vis Sci 2001;42:1087–1095.

    PubMed  CAS  Google Scholar 

  42. Nakamura M SD, Kubo E, Chylack LT Jr, Shinohara T. LEDGF: survival of embryonic chick retinal photoreceptor cells. Invest Ophthalmol Vis Sci 2000;41:1168–1175.

    PubMed  CAS  Google Scholar 

  43. Song Y, Zhao L, Tao W, Laties AM, Luo Z, Wen R. Photoreceptor protection by cardiotrophin-1 in transgenic rats with the rhodopsin mutation s334ter. Invest Ophthalmol Vis Sci 2003;44:4069–4075.

    Article  PubMed  Google Scholar 

  44. Liu C, Li Y, Peng M, Laties AM, Wen R. Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation s334ter during photoreceptor degeneration. J Neurosci 1999;19:4778–4785.

    PubMed  CAS  Google Scholar 

  45. Aguirre G, Farber D, Lolley R, et al. Retinal degenerations in the dog III abnormal cyclic nucleotide metabolism in rod-cone dysplasia. Exp Eye Res 1982;35:625–642.

    Article  PubMed  CAS  Google Scholar 

  46. Ray K, Baldwin VJ, Acland GM, Blanton SH, Aguirre GD. Cosegregation of codon 807 mutation of the canine rod cGMP phosphodiesterase beta gene and rcd1. Invest Ophthalmol Vis Sci 1994;35:4291–4299.

    PubMed  CAS  Google Scholar 

  47. Wu WC, Lai CC, Chen SL, et al. GDNF gene therapy attenuates retinal ischemic injuries in rats. Mol Vis 2004;10:93–102.

    PubMed  CAS  Google Scholar 

  48. Lindqvist N, Peinado-Ramonn P, Vidal-Sanz M, Hallbook F. GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection. Exp Neurol 2004; 187:487–499.

    Article  PubMed  CAS  Google Scholar 

  49. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 1993;602:304–317.

    Article  PubMed  CAS  Google Scholar 

  50. Ko ML, Hu DN, Ritch R, Sharma SC, Chen CF. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett 2001;305:139–142.

    Article  PubMed  CAS  Google Scholar 

  51. Watanabe M, Fukuda Y. Survival and axonal regeneration of retinal ganglion cells in adult cats. Prog Retin Eye Res 2002;21:529–553.

    Article  PubMed  Google Scholar 

  52. Van Adel BA, Kostic C, Deglon N, Ball AK, Arsenijevic Y. Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time. Hum Gene Ther 2003;14:103–115.

    Article  PubMed  CAS  Google Scholar 

  53. Ji JZ EW, Yip HK, Lee VW, Yick LW, Hugon J, So KF. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur J Neurosci 2004;19:265–272.

    Article  PubMed  Google Scholar 

  54. Rizzo LV XH, Chan CC, Wiggert B, Caspi RR. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 1998;10:807–814.

    Article  PubMed  CAS  Google Scholar 

  55. Rosenbaum JT, Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. J Immunol 1995;155:4090–4094.

    PubMed  CAS  Google Scholar 

  56. De Kozak Y, Thillaye-Goldenberg B, Naud MC, Da Costa AV, Auriault C, Verwaerde C. Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene. Clin Exp Immunol 2002;130:212–223.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurotech USA, Lincoln, RI

    Weng Tao MD, PhD

  2. Department of Ophthalmology, University of Pennsylvania, School of Medicine, Philadelphia, PA

    Rong Wen MD, PhD

Authors
  1. Weng Tao MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rong Wen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT

    Joyce Tombran-Tink PhD  & Colin J. Barnstable DPhil  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Tao, W., Wen, R. (2007). Application of Encapsulated Cell Technology for Retinal Degenerative Diseases. In: Tombran-Tink, J., Barnstable, C.J. (eds) Retinal Degenerations. Ophthalmology Research. Humana Press. https://doi.org/10.1007/978-1-59745-186-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-186-4_21

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-620-7

  • Online ISBN: 978-1-59745-186-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation